Efficacy and safety of fecal microbiota transplantation for the treatment of diseases other than Clostridium difficile infection: a systematic review and meta-analysis

Simple item page
dc.contributor.authorGreen, Jessica Emily
dc.contributor.authorDavis, Jessica A.
dc.contributor.authorBerk, Michael
dc.contributor.authorHair, Christopher
dc.contributor.authorLoughman, Amy
dc.contributor.authorCastle, David
dc.contributor.authorAthan, Eugene
dc.contributor.authorNierenberg, Andrew A.
dc.contributor.authorCryan, John F.
dc.contributor.authorJacka, Felice N.
dc.contributor.authorMarx, Wolfgang
dc.date.accessioned2022-04-07T10:26:16Z
dc.date.available2022-04-07T10:26:16Z
dc.date.issued2020-11
dc.date.updated2022-04-07T09:06:39Z
dc.description.abstractThe intestinal microbiome has been identified as a key modifier for a variety of health conditions. Fecal Microbiota Transplantation (FMT) has emerged as a fast, safe, and effective means by which to modify the intestinal microbiome and potentially treat a variety of health conditions. Despite extensive research of FMT for CDI, there is a lack of clarity informed by systematic synthesis of data regarding the safety and efficacy of FMT for other health conditions. This systematic review used PRISMA guidelines and was prospectively registered with PROSPERO (CRD42018104243). In March 2020, a search of MEDLINE, EMBASE, and PsycINFO was conducted. We identified 26 eligible studies. A meta-analysis of FMT for active Ulcerative Colitis (UC) showed that FMT significantly improved rates of clinical remission (OR = 3.634, 95% CI = 1.940 to 6.808, I-2 = 0%, p< .001), clinical response (OR = 2.634, 95% CI = 1.441 to 4.815, I2 = 33%, p = .002) and endoscopic remission (OR = 4.431, 95% CI = 1.901 to 10.324, I2 = 0%, p = .001). With respect to Irritable Bowel Syndrome, a meta-analysis showed no significant change in symptoms following FMT (p = .739). Hepatic disorders, metabolic syndrome, and antibiotic-resistant organisms were conditions with emerging data on FMT. Serious adverse events (AE) were more often reported in control group participants (n = 43) compared with FMT group participants (n = 26). There were similar rates of mild to moderate AE in both groups. Preliminary data suggest that FMT is a potentially safe, well-tolerated and efficacious treatment for certain conditions other than CDI, with evidence for active UC being the most compelling.en
dc.description.statusPeer revieweden
dc.description.versionPublished Versionen
dc.format.mimetypeapplication/pdfen
dc.identifier.citationGreen, J. E., Davis, J. A., Berk, M., Hair, C., Loughman, A., Castle, D., Athan, E., Nierenberg, A. A., Cryan, J. F., Jacka, F. N. and Marx, W. (2020) 'Efficacy and safety of fecal microbiota transplantation for the treatment of diseases other than Clostridium difficile infection: a systematic review and meta-analysis', Gut Microbes, 12 (1), (25pp). doi: 10.1080/19490976.2020.1854640en
dc.identifier.doi10.1080/19490976.2020.1854640en
dc.identifier.endpage25en
dc.identifier.issn1949-0976
dc.identifier.issued1en
dc.identifier.journaltitleGut Microbesen
dc.identifier.startpage1en
dc.identifier.urihttps://hdl.handle.net/10468/13047
dc.identifier.volume12en
dc.language.isoenen
dc.publisherTaylor & Francisen
dc.rights© 2020 The Author(s). Published with license by Taylor & Francis Group, LLC. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.en
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/en
dc.subjectFecal microbiota transplantation clostridium difficileen
dc.subjectMicrobiomeen
dc.subjectMeta- analysisen
dc.subjectRCTen
dc.subjectSystematic reviewen
dc.subjectUlcerative colitisen
dc.subjectIrritable bowel syndromeen
dc.subjectPsychiatryen
dc.subjectMental disorderen
dc.subjectNeuroscienceen
dc.subjectDepressionen
dc.titleEfficacy and safety of fecal microbiota transplantation for the treatment of diseases other than Clostridium difficile infection: a systematic review and meta-analysisen
dc.typeArticle (peer-reviewed)en
Files
Original bundle
Now showing 1 - 2 of 2
Thumbnail Image
Name:
Efficacy_and_safety_of_fecal_microbiota_transplantation_for_the_treatment_of_diseases_other_than_Clostridium_difficile_infection_a_systematic_review.pdf
Size:
1.74 MB
Format:
Adobe Portable Document Format
Description:
Published Version
Download
Thumbnail Image
Name:
kgmi_a_1854640_sm0716 (1).docx
Size:
505.08 KB
Format:
Microsoft Word XML
Description:
Supplemental Material
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
2.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
APC Microbiome Ireland - Journal Articles
Anatomy and Neuroscience - Journal Articles
Psychiatry - Journal Articles